JavaScript is disabled in your browser. Please enable JavaScript to view this website.
AB263124

Human C19orf48 knockout HEK-293T cell lysate

Be the first to review this product! Submit a review

|

(0 Publication)

C19orf48 KO cell lysate available now. KO validated. Free of charge wild type control included. Knockout achieved by using CRISPR/Cas9, 1 bp insertion in exon4 and 5 bp deletion in exon4 and Insertion of the selection cassette in exon4.
3 Images
Sanger Sequencing - Human C19orf48 knockout HEK-293T cell lysate (AB263124)
  • Sanger seq

Unknown

Sanger Sequencing - Human C19orf48 knockout HEK-293T cell lysate (AB263124)

Allele-2 : 1 bp insertion in exon4

Sanger Sequencing - Human C19orf48 knockout HEK-293T cell lysate (AB263124)
  • Sanger seq

Unknown

Sanger Sequencing - Human C19orf48 knockout HEK-293T cell lysate (AB263124)

Allele-3 : Insertion of the selection cassette in exon4

Sanger Sequencing - Human C19orf48 knockout HEK-293T cell lysate (AB263124)
  • Sanger seq

Unknown

Sanger Sequencing - Human C19orf48 knockout HEK-293T cell lysate (AB263124)

Allele-1 : 5 bp deletion in exon4

Key facts

Cell type

HEK-293T

Species or organism

Human

Tissue

Kidney

Knockout validation

Sanger Sequencing

Mutation description

Knockout achieved by using CRISPR/Cas9, 1 bp insertion in exon4 and 5 bp deletion in exon4 and Insertion of the selection cassette in exon4.

Product details

Knockout cell lysate achieved by CRISPR/Cas9.

REACH authorisation
Abcam has not and does not intend to apply for the REACH Authorisation of customers' uses of products that contain European Authorisation list (Annex XIV) substances.
It is the responsibility of our customers to check the necessity of application of REACH Authorisation, and any other relevant authorisations, for their intended uses.

Lysate preparation: Our lysates are made using RIPA buffer to which we add a protease inhibitor cocktail and phosphatase inhibitor cocktail (ratio: 300:100:10). This means that the protein of interest is denatured. If you require a native form of the protein please use the live cell version. Please refer to our lysis protocol for further details on how our lysates are prepared.

User storage instructions: Lyophilizate may be stored at 4°C. After reconstitution, store at -20°C for short-term storage or -80°C for long-term storage.

This product is subject to limited use licenses from The Broad Institute, ERS Genomics Limited and Sigma-Aldrich Co. LLC, and is developed with patented technology. For full details of the licenses and patents please refer to our limited use license and patent pages.

What's included?

{ "values": { "1Kit": { "sellingSize": "1 Kit", "publicAssetCode":"ab263124-1Kit", "assetComponentDetails": [ { "size":"1 x 100 µg", "name":"Human C19orf48 knockout HEK293T cell lysate", "number":"AB263124-CMP01", "productcode":"" }, { "size":"1 x 100 µg", "name":"Human wild-type HEK293T cell lysate", "number":"AB263124-CMP02", "productcode":"" } ] } } }

Properties and storage information

Gene name
C19orf48
Gene editing type
Knockout
Gene editing method
CRISPR technology
Knockout validation
Sanger Sequencing
Shipped at conditions
Ambient - Can Ship with Ice
Appropriate short-term storage conditions
-20°C
Appropriate long-term storage conditions
-20°C

Supplementary information

This supplementary information is collated from multiple sources and compiled automatically.

C19orf48 also known as Chromosome 19 Open Reading Frame 48 is a protein encoded by the C19orf48 gene. This protein has a molecular mass of approximately 17.5 kDa. It has been found to be expressed in various tissues with notable levels in the brain and immune tissues. The precise mechanism of its action remains under investigation but it has been suggested to play a role in cellular processes related to transcription regulation.
Biological function summary

C19orf48 functions within the context of transcriptional control. While it is not currently identified as part of a large protein complex emerging evidence hints at its involvement in modulating the expression of certain genes. This implies a potential influence on cellular decision-making processes. By impacting gene expression C19orf48 may contribute to a variety of cellular outcomes many of which are relevant to the function of the nervous and immune systems.

Pathways

Studies indicate that C19orf48 participates in pathways associated with gene expression regulation and immune response. It is thought to have a connection with the NF-κB signaling pathway a critical mediator of immune and inflammatory responses. The protein may act alongside others like NFKBIA which is known to inhibit this pathway under specific conditions. Understanding of these interactions helps elucidate the broader roles that C19orf48 may play in cellular signaling networks.

Research has associated C19orf48 with neurological and immune-related conditions. Altered expression levels have been observed in certain types of cancers especially in gliomas suggesting a potential role in tumorigenesis. Additionally connections with proteins such as p53 have been noted which are important in cancer biology due to their involvement in cell cycle regulation and apoptosis. Further investigation is necessary to fully characterize these relationships and their implications for disease progression and therapy.

Quality control

STR analysis

CSF1PO, D13S317, D7S820, D5S818, TH01, D16S539, TPOX

Cell culture

Biosafety level

EU: 2 US: 2

Adherent/suspension

Adherent

Gender

Female

Product protocols

Product promise

We are committed to supporting your work with high-quality reagents, and we're here for you every step of the way. In the unlikely event that one of our products does not perform as expected, you're protected by our Product Promise.
For full details, please see our Terms & Conditions

Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.

For licensing inquiries, please contact partnerships@abcam.com